Basma Radwan
Stock Analyst at Leerink Partners
(1.05)
# 3,878
Out of 5,036 analysts
3
Total ratings
n/a
Success rate
-11.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Basma Radwan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LRMR Larimar Therapeutics | Reiterated: Buy | $13 | $2.82 | +360.99% | 1 | Sep 14, 2026 | |
| PTCT PTC Therapeutics | Initiated Coverage: Buy | $98 | $63.55 | +54.22% | 1 | Sep 14, 2026 | |
| RYTM Rhythm Pharmaceuticals | Initiated Coverage: Buy | $133 | $90.96 | +46.22% | 1 | Sep 14, 2026 |
Larimar Therapeutics
Sep 14, 2026
Reiterated: Buy
Price Target: $13
Current: $2.82
Upside: +360.99%
PTC Therapeutics
Sep 14, 2026
Initiated Coverage: Buy
Price Target: $98
Current: $63.55
Upside: +54.22%
Rhythm Pharmaceuticals
Sep 14, 2026
Initiated Coverage: Buy
Price Target: $133
Current: $90.96
Upside: +46.22%